Skip to main content
Beat Cancer EU Website Logo
IGHG Ototoxicity Guideline
Quality of LifeAllGuidelines

IGHG Ototoxicity Guideline

Recommendations for surveillance for ototoxicity (hearing loss, tinnitus, or both) in survivors who were treated with platinum chemotherapy or radiotherapy to the brain or ear.

Year:2019

Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems. Because of this high risk survivors may benefit from surveillance for hearing loss.

Discussion & Questions

Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.

Leave a Comment

Minimum 10 characters, maximum 2000 characters

No comments yet

Be the first to share your thoughts!